Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

The Executive Director of the Ghana Foundation for Sickle Gene Action, Victoria Awo Twumasi, has appealed to President John Dramani Mahama to include full coverage of sickle cell disease (SCD) treatme ...

The misshapen cells tend to block blood flow in the vessels, leading to frequent pain episodes, infections, and damage to organs.

Rising sickle cell disease in children demands urgent awareness. Early diagnosis, modern therapies, and vigilant care can ...

A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

When Graham Serjeant arrived in Jamaica in 1966, it was accepted wisdom that few of those affected by sickle cell disease (SCD) survived beyond childhood. Yet he encountered adult patients living with ...

Hemoglobinopathies Market The hemoglobinopathies market is advancing rapidly, driven by gene therapy, new drugs, and rising access for trea ...